Concepedia
Statistics
Publications
22
Citations
1.8K
H-Index
20
Active since
2006
Affiliations
Imperial College London(Current)
Hammersmith Hospital
Ninewells Hospital
University of Dundee
Cancer Research UK
Manikandan Periyasamy is an author at Imperial College London specializing in molecular oncology, oncology, and molecular biology.
Publications per year
2006–2024
Genomic modelling of the ESR1 Y537S mutation for evaluating function and new therapeutic approaches for metastatic breast cancer
Alison Harrod, J Fulton, Van T.M. Nguyen et al. · Oncogene · 2016 · 180 citations · Full text
Life Sciences, Molecular Biology, Molecular Genetics +17
The Development of a Selective Cyclin-Dependent Kinase Inhibitor That Shows Antitumor Activity
Simak Ali, Dean A. Heathcote, Sebastian H. B. Kroll et al. · Cancer Research · 2009 · 163 citations · Full text
Life Sciences, Medicinal Chemistry, Pharmacology +16
ICEC0942, an Orally Bioavailable Selective Inhibitor of CDK7 for Cancer Treatment
Hetal Patel, Manikandan Periyasamy, Georgina P. Sava et al. · Molecular Cancer Therapeutics · 2018 · 140 citations · Full text
Medicine, Oncology, Pharmacology +16
Differential epigenetic reprogramming in response to specific endocrine therapies promotes cholesterol biosynthesis and cellular invasion
Van T.M. Nguyen, Iros Barozzi, Monica Faronato et al. · Nature Communications · 2015 · 137 citations · Full text
Medicine, Cancer Biology, Oncology +17
APOBEC3B-Mediated Cytidine Deamination Is Required for Estrogen Receptor Action in Breast Cancer
Manikandan Periyasamy, Hetal Patel, Chun‐Fui Lai et al. · Cell Reports · 2015 · 117 citations · Full text
Life Sciences, Genetics, Molecular Biology +17
1–5 of 22